Thermo Fisher Scientific
Thermo Fisher Scientific Inc. provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services worldwide. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, and diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and research and industrial markets, as well as clinical laboratories. The company’s Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems and antibody tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; cancer diagnosis and medical research products; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, and ultralow-temperature freezers and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics and chemicals; and pharma services. It has collaboration with WuXi Diagnostics and Mayo Clinic to develop antibodies tests; a strategic collaboration with Schrödinger, Inc.; an agreement with Daiichi Sankyo; collaboration with Northeastern University; and partnership with Boys & Girls Clubs of America. The company was incorporated in 1956 and is headquartered in Waltham, Massachusetts.
Past deals in Chemical
B.R.A.H.M.S.(Brahms)
Acquisition in 2009
B·R·A·H·M·S explores, develops and produces new diagnostic test procedures to improve the diagnosis, and thereby the treatment, of life-threatening illnesses.
This takes place with over 400 employees, on the basis of their own patented biomarkers, and leads to medically and economically superior diagnostic insights for patients and medical professionals.
B·R·A·H·M·S products reach customers in over 65 countries around the world and are leaders in their specialized markets.
Core Informatics
Acquisition in 2017
Core Informatics is a software company focused on delivering web-based LIMS software to customers in a variety of industries. Its data management software helps accelerate scientific discovery and collaboration.
The company offers Platform for Science, a comprehensive lab informatics platform for scientists, IT engineers, and business leaders who demand more from their informatics solutions. The platform supports the rapid configuration and deployment of a range of products, applications, and solutions. The company’s RESTful APIs enable integrations and data exchange with other systems, and allow Platform for Science to fit into existing IT environments without adding undue complexity.
Core Informatics also offers many other products such as Core LIMS for lab information management, Core ELN for lab notebook data management, Core SDMS for instrument integration and automated data capture, and Core Collaboration for secure data exchange and storage across teams.
Founded in 2005, Core Informatics is based in Branford, Connecticut.
GE Healthcare Dharmacon, Inc.
Acquisition in 2004
Based in Lafayette, Colo., Dharmacon, Inc. is a leading provider of reliable and high quality RNA oligonucleotides, small interfering RNA (siRNA) and related RNA-interference (RNAi) products and technologies to the life-sciences industry. Using its core expertise in chemistry, biology, bioinformatics and production, Dharmacon has pioneered a custom siRNA design service for maximizing the efficiency of gene silencing, a powerful and increasingly widely-used new technology based on siRNA.
Thermo Hypersil-Keystone
Acquisition in 2000
Thermo Hypersil-Keystone LLC manufactures and supplies instrumentation and laboratory equipment such as packed columns and accessories for chromatography; general purpose, base deactivated, reversed and normal phase, and specialty columns for the analysis of proteins, peptides and biomolecules.
FEI Company
Acquisition in 2016
With more than 60 years of microscopy innovation and leadership, FEI enables customers to find meaningful answers to questions that accelerate breakthrough discoveries, increase productivity, and ultimately change the world. FEI designs, manufactures, and supports the broadest range of high-performance microscopy workflow solutions that provide images and answers in the micro-, nano-, and picometer scales.
Keystone Scientific
Acquisition in 2000
Keystone was founded in 1985 by Dr. Richard A. Henry, a highly respected chromatographer with 30 years of experience, and Director of Analytical Laboratories at Penn State University. Dr. Henry is still active in the company as Technical Director, where he sets a high standard for technical support and development of innovative products.
Keystone specializes in preparing packed columns for HPLC, SFC and CEC, plus the supplies and accessories that allow columns to be used properly.
KSI now occupies various buildings and employs many competent, experienced chemists. The different departments of KSI work together to provide the customer with a high quality product, fast service, excellent customer service and technical support.
QIAGEN N.V.
Acquisition in 2020
Founded in 1984, QIAGEN is a provider of sample and assay technologies. The company has developed and market more than 500 consumable products and automated solutions to academic researchers, pharmaceutical and biotechnology companies.
HighChem Ltd.
Acquisition in 2019
HighChem Ltd. designs and develops mass spectrometry software solutions. The company was founded in 1998 and is based in Bratislava, Slovakia. As of June 6, 2019, HighChem Ltd. operates as a subsidiary of Thermo Fisher Scientific Inc.
Alfa Aesar
Acquisition in 2015
Part of the Johnson Matthey group of companies, Alfa Aesar is a leading manufacturer and supplier of research chemicals, metals and materials in a wide span of applications. For more than 50 years, scientists have relied on Alfa Aesar to supply high purity raw materials for a variety of research and development applications. Today they offer over 45,000 products in stock, in sizes from gram-scale catalog items to semi-bulk and bulk production quantities. With custom manufacturing capabilities to supply many more specialized items, they are a one-stop source for research chemicals, metals and materials.
Their product line consists of a comprehensive range of inorganic, organic and organometallic compounds; pure metals and elements; precious metal compounds and catalysts; biochemicals; fuel cell products; nanomaterials; rare earths; analytical products; and select laboratory equipment. Backed by the global manufacturing network of Johnson Matthey and other key partnerships, they offer customers the highest quality and purity in fine chemical products. They are accustomed to supplying R&D laboratories in the pharmaceutical industry and the electronics industry, as well as academic institutions and many others.
Alfa Aesar is a trusted, service-oriented company. Product quality is of paramount importance, but production expertise is just the beginning. Factors such as product availability, packaging and delivery are just as crucial to meeting and exceeding your expectations. Their established quality process ensures a high level of service and a promise of continually striving for perfection. With most catalog items in stock for same-day shipment, and a friendly and knowledgeable staff, they provide customers with an unsurpassed level of service.
Oxoid
Acquisition in 2004
Oxoid, with sales and operations in Europe, North and South America and Australia, is one of the world's leading manufacturers of microbiological culture media and other diagnostic products. Oxoid's products are used in microbiology laboratories, food testing, and biopharmaceutical production and process validation to isolate and identify bacteria or other organisms. Through its rigorous attention to quality and service, Oxoid has earned an unparalleled reputation for helping its customers ensure that their products are free from bacterial contamination. The company is headquartered in Basingstoke, England.
Clintrak
Acquisition in 2006
Clintrak's mission is to provide the healthcare industry with the most responsive, accurate and high-quality labeling solutions for use in clinical trials.
Clintrak Pharmaceutical Services is a leading provider of clinical-trial printing services, including single panel label and booklet label design and production, to pharmaceutical and biotechnology companies worldwide. The company's booklet label services offer customers an accurate and cost-effective method of providing labels for global, multi-lingual clinical trials. Along with its wholly owned subsidiary, Acculogix, the company also provides clinical-trial materials and supply-chain management services for all stages of a clinical trial.
Phitonex, Inc.
Acquisition in 2020
Phitonex, Inc. is developing the next generation of fluorescent labels and instrumentation to advance the fight against disease. Phitonex reagents provide a cost-effective, non-destructive method to obtain more information about critical molecular biomarkers, simplifying experimental design and accelerating the discovery process. As a Duke University spin-out, the company’s co-founders have over 15 years of collaborative experience engineering labels at the molecular level to tailor their fluorescence properties.
Sterilin
Acquisition in 2011
Sterilin Limited manufactures and supplies disposable plastic products. The company provides disposable plastics, including petri dishes, sample containers, pipettes, and multiwell plates for life science, microbiology, and clinical markets; packaging products, such as a range of regular bottles in HDPE, LDPE, or PP with dispensing, child resistant, and tamper evident closure options; and a range of moulded and extruded silicone products, which include cones, discs, pipette bulbs, sheeting, stoppers, test tube holders, and tubing.
Lomb Scientific
Acquisition in 2010
Lomb Scientific is a major supplier of laboratory consumables, chemicals and instrumentation to the scientific community. Lomb was originally acquired by Walter Parsons in 1984. At the time it was a niche manufacturer and supplier of microscope slides and coverslips. Under Walter's stewardship together with a loyal senior management team, the organisation flourished and the continued growth resulted in several moves to larger, better equipped facilities culminating in the relocation of the Head Office to a purpose built office and warehouse facility. At the same time we established office and warehouse facilities across the rest of Australia and New Zealand.
Lomb Scientific's strong organic growth accelerated in recent times with the purchase of Scot Scientific, Fronine and Ajax Finechem. Scot improved our Western Australian coverage for clients. Fronine improved our manufacturing and supply of pathology stains and solvents. Ajax Finechem improved our exclusive company owned brands in chemicals and solvents for our client base. These acquisitions now form the basis of the Lomb group of companies that aspire to support the advance of science better than any other organisation.
Affymetrix
Acquisition in 2016
Affymetrix now develops and provides innovative technologies that enable multiplex and parallel analysis of biological systems at the cell, protein, and gene level, facilitating the rapid translation of results into biology for a better world.
Brammer Bio, LLC
Acquisition in 2019
Brammer Bio, LLC develops and manufactures cell and gene therapies for pharmaceutical and biotechnology industries. It offers pre-clinical process and analytical development, process optimization, process scale-up, process and analytical qualification, and clinical and commercial supply of drug substances and formulated drug products. The company was formerly known as Brammer Biopharmaceuticals, LLC and changed its name in Brammer Bio, LLC in April 2016. Brammer Bio, LLC was incorporated in 2013 and is based in Cambridge, Massachusetts. As of April 30, 2019, Brammer Bio, LLC operates as a subsidiary of Thermo Fisher Scientific Inc.
Perbio Science
Acquisition in 2003
Perbio Science focuses on proteins. Our products, systems, and services allow our customers who are life science researchers and biopharmaceutical companies to understand and to produce proteins faster, easier, and more economically. The ultimate market driver is the quest for longer, better quality of life for both humans and animals by the development of more and better medicines.
Perbio Science is organized into three divisions. The Bioresearch Division provides kits, reagents, and services for identifying, quantifying, purifying and modifying proteins in addition to amidites and nucleotides for nucleic acid-based drugs and diagnostics. The Cell Culture Division is a leader in providing proper nutrition for animal cells in culture, process liquids for protein purification, sterile liquid handling systems, and disposable, sterile liquid processing systems. The Medical Device Division focuses on the ears, nose and throat area, especially voice rehabilitation of laryngectimized patients.
The head office of Perbio Science is located in Helsingborg, Sweden.
On 31th of March, 2003, Perbio Science had 1314 employees worldwide.
QIAGEN N.V.
Acquisition in 2020
Founded in 1984, QIAGEN is a provider of sample and assay technologies. The company has developed and market more than 500 consumable products and automated solutions to academic researchers, pharmaceutical and biotechnology companies.
Kendro Laboratory Products
Acquisition in 2005
Kendro is a global leader in sample preparation products and services for life science, material science and drug discovery applications.
Kendro designs, manufactures, markets and services a wide range of laboratory equipment for sample preparation, processing and storage used primarily in life sciences and drug discovery laboratories as well as in clinical laboratories.
Kendro's centrifuge offerings, known to customers by names such as Sorvall(R) and Heraeus(R), cover applications ranging from the separation of DNA to the separation of whole cells for use in biochemistry, molecular biology, virology, diagnostics and other clinical and research applications. Kendro's thermal equipment offerings include ovens, incubators, freezers and refrigerators for research and industrial applications, marketed under the brands Revco(R) and Jewett(R). In addition to equipment solutions, Kendro provides its customers with comprehensive services through a global network of technicians, and offers integrated validation services and bio-repositories for sample storage and laboratory relocation management.
IonPath, Inc.
Corporate Round in 2022
Ionpath is a developer of an ion beam imaging technology used to provide analysis of tissue biopsies. Its imaging technology surpasses light microscopy to analyze whether the tissues are fresh, frozen, or FFPE that enable healthcare providers to provide a diagnosis of cancer for improving human health.
MTI-GlobalStem
Acquisition in 2016
MTI-GlobalStem has an active research program that utilizes expertise in transfection, neuroscience and stem cell biology to develop and supply scientists with the necessary tools and reagents to help advance new discoveries and developments in the life sciences. Utilizing our intellectual property and know-how, and a specialized team of highly skilled and experienced scientists, we are filling the gap with primary and iPSC-derived neural cells, stem cells and supporting feeder cells, optimized growth media and supplements, and an innovative platform of novel targeted reagents used to deliver nucleic acids into stem cells and neuronal cells with maximum efficiency.
Henogen
Acquisition in 2021
Henogen is a biotechnology company addressing biomanufacturing issues under the general umbrella "from gene to the clinical product.
Proxeon
Acquisition in 2010
Proxeon develops solutions to solve many of the scientific and technical challenges that are faced by those working in the field of proteomics.
The proteomics field draws on a wide range of knowledge, including biology, physics, engineering and informatics. Scientists at Proxeon have been actively involved in proteomics research for more than 15 years and have a proven track record in development of high quality products.
With core competencies in the areas of mass spectrometry, protein analysis, hardware and software design for proteome analysis, Proxeon is capable of developing solutions, and creating a new generation of powerful proteomics tools.
NovaWave Technologies
Acquisition in 2010
NovaWave Technologies (NWT) was founded and incorporated in 2002 with the mission to develop optically-based chemical detection instrumentation for military and civilian markets, including homeland defense, environmental monitoring, metrology, and basic and applied research. Additionally, NWT is developing novel microfluidic systems for biomedical applications in clinical diagnostics and biological agent detection.
The team at NWT consists of top-notch scientific, management, and marketing personnel. The company has also formed strategic partnerships with key industry leaders in chemical detection instrumentation and manufacturing. These relationships allow NWT to rapidly produce low cost, high performance sensor systems for worldwide markets. Please contact NWT to discuss partnering or teaming opportunities in our various program areas.
Polychromix
Acquisition in 2010
Polychromixâ is an advanced communications technology company providing modular optical subsystems. Polychromix’s products are based on an innovative core technologies that enable dynamically configurable optical networks.
Intrinsic Bioprobes Inc.
Acquisition in 2011
Intrinsic Bioprobes is a biotechnology company. Moreover, the company is a manufacturer of immuno-enrichment, sample-preparation tools used in quantitative mass spectrometry.
Founded in 1996, the company is headquartered in Tempe, Arizona.
Mesa Biotech
Acquisition in 2021
Mesa Biotech, Inc. designs, develops, manufactures, and commercializes molecular diagnostic tests. Its products include Accula Dock that controls reaction temperatures, timing, and fluid movements within the Accula test cassettes; Accula Influenza A/B test cassettes; and Accula respiratory syncytial virus test cassettes. Mesa Biotech, Inc. was founded in 2015 and is based in San Diego, California with a satellite testing laboratory in Santa Fe, New Mexico.
Priority Solutions International
Acquisition in 2007
Priority Solutions International provides global supply chain management services. The Company offers logistics services such as warehousing, order management, shipment preparation, international air freight forwarding, and reverse logistics.
TREK Diagnostic Systems
Acquisition in 2011
Trek is part of Thermo Fisher Scientific, the world leader in serving science. Thermo Fisher enable their customers to make the world healthier, cleaner and safer by providing analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery and diagnostics. With revenues of nearly $11 billion, they have approximately 37,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries.
Pharmaceutical Product Development
Acquisition in 2021
PPD is a global contract research organization (CRO) providing discovery, development and post-approval services as well as compound partnering programs. Their clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations.
Dionex Corporation
Acquisition in 2010
Dionex Corporation develops, manufactures, sells, and services chromatography and extraction systems for separating, isolating, and identifying the components of chemical mixtures.
Their continuing leadership in chromatography helps us create powerful solutions to increase productivity for the industries that shape the world. Their solutions are used by the environmental, life sciences, pharmaceutical, food and beverage, chemicals, power generation, and electronics industries.
INEL
Acquisition in 2016
INEL was incorporated in 1984 and converted into a joint venture in 1986 between Lucas Indian Service Ltd, a wholly-owned subsidiary of Lucas-TVS Ltd and MAHLE Electric Drives Japan Corporation, Japan - a company of MAHLE Group, Germany, to manufacture Electronic Ignition Systems for two-wheelers, three wheelers and portable engines. Over the years the company has enlarged its customer base and now supplies to most of the manufacturers of two-wheelers, three wheelers and gensets. Company's net sales for the year ended March, 2015 was Rs.3274 Million (USD 50 Million). INEL makes the entire range of 2/3 wheelers, digital and analog ignition products.
Life Technologies
Acquisition in 2014
Life Technologies Corporation operates as a biotechnology tools company. The company's systems, consumables and services enable researchers to accelerate scientific exploration, to discoveries and developments.
Life Technologies was created by the combination of [Invitrogen Corporation](/organization/invitrogen) and [Applied Biosystems, Inc.](/organization/applied-biosystems) in November of 2008, and Life Technologies continues to serve its customers under those two well-known brands. Invitrogen is the premier provider of reagents and consumables that are usable across multiple platforms, while Applied Biosystems remains the top provider of systems-based, end-to-end solutions in areas such as PCR, genetic sequencing, and mass spectrometry.
The company delivers a range of products and services, including systems, instruments, reagents, and custom services. Its portfolio of products includes technologies for capillary electrophoresis based sequencing, sequencing, mass spectrometry, sample preparation, cell culture, RNA interference analysis, functional genomics research, proteomics and cell biology applications, as well as clinical diagnostic applications and water testing analysis.
EGS Gauging
Acquisition in 2006
EGS Gauging Inc is one of the world's largest suppliers of measurement and control products for web process applications in the plastics processing and converting industries.
They have the resources and the vision to bring their customers into the future with a full complement of innovative web gauging and control systems and services. But the proof is in the numbers: With almost 3000 EGS Gauging systems installed worldwide, and a higher than 75% repeat business rate, the clear message from OEMs and users is that EGS Gauging solutions continue to be the clear choice for quality, reliability, performance and results.
From the Americas to Zimbabwe, and more than 50 countries in between, EGS Gauging systems are hard at work delivering top-of-the-line measurement performance for plants of all sizes.
NanoDrop Technologies
Acquisition in 2007
NanoDrop Technologies manufactures and sells unique analytical instruments based upon patented sample retention technology. Their instruments are used globally in biotechnology, pharmaceutical and life science research.
NanoDrop develops, manufactures and sells unique laboratory instruments which photometrically analyze 1 ul samples. The patented sample retention technology was originally developed in the DuPont Agricultural Genomics Laboratories and has been in use since 1998.
Doe & Ingalls
Acquisition in 2012
Doe & Ingalls aspires to help life science and microelectronics customers build more secure, robust and transparent supply chains. They do this by providing chemicals, complementary supply chain services and market insight to their customers.
Fermentas International
Acquisition in 2010
With origins dating back to the 1970s, Fermentas produced molecular biology products for scientific research. Fermentas grew to be the dominant player in Europe, and sought an experienced life sciences partner to solidify this leading position while helping expand geographically into North America and Asia.
Omega Data Systems
Acquisition in 2006
Netherlands-based Omega Data Systems, developer of the world renowned UniQuant XRF analysis package. UniQuant® is software for use with a sequential X-Ray Fluorescence (XRF) Spectrometer.
It enables quantitative elemental analysis of samples without or with the use of standards.
One Lambda
Acquisition in 2012
One Lambda develops and distributes several lines of histocompatibility (HLA) typing tests utilizing both serological and molecular technologies. One Lambda also manufactures a comprehensive line of antibody detection products, laboratory instrumentation, and computer software that are used to simplify and automate testing procedures and final test evaluations.
Rupprecht and Patashnick (R&P)
Acquisition in 2005
Since its formation in 1981, R&P has established a global reputation for developing innovative and reliable high performance instrumentation designed to meet the most demanding regulatory applications for continuous particulate monitoring. Headquartered in East Greenbush, New York, R&P will become part of the Air Quality Instruments product line within Thermo's Environmental Instruments division.
Brammer Bio, LLC
Acquisition in 2019
Brammer Bio, LLC develops and manufactures cell and gene therapies for pharmaceutical and biotechnology industries. It offers pre-clinical process and analytical development, process optimization, process scale-up, process and analytical qualification, and clinical and commercial supply of drug substances and formulated drug products. The company was formerly known as Brammer Biopharmaceuticals, LLC and changed its name in Brammer Bio, LLC in April 2016. Brammer Bio, LLC was incorporated in 2013 and is based in Cambridge, Massachusetts. As of April 30, 2019, Brammer Bio, LLC operates as a subsidiary of Thermo Fisher Scientific Inc.
Finesse Solutions, Inc.
Acquisition in 2017
Finesse Solutions, Inc., a leader in the development of scalable control automation systems and software for bioproduction.
Its proprietary Smart technology, which consists of sensors, controllers and software, is designed to optimize the bioproduction workflow.
Princeton Security Technologies
Acquisition in 2012
Princeton Gamma-Tech Instruments is a leading supplier of X-ray and Gamma-ray Detectors and Spectroscopy systems, portable Radioisotope Identifiers, and portable Chemical Analyzers. We serve a broad customer base in scientific research, industrial materials analysis, and Home Land Security. PGT operates a full customer service and Reachback program, backed by a modern manufacturing and service facility.
Princeton Gamma-Tech has been a leader in the field of semiconductor gamma- and X-ray detectors for over 30 years. When General Electric first produced high-purity (intrinsic) germanium crystals in 1972-73, PGT manufactured the first commercial HPGe planar detectors, soon followed by the first HPGe coaxials. Since that time, PGT HPGe detectors have explored outer space, gone to the depths of mines in search of beta-beta decay in enriched germanium, and found uses throughout the world in nuclear power plants, environmental measurements, and aerospace studies.
Finnzymes Oy
Acquisition in 2010
Finnzymes works intensively at the leading edge of PCR and transposon technologies. High quality science has been the backbone of the company since its foundation in 1986. Finnzymes' employees are skilled, motivated and creative scientists, dedicated to the company's simple but demanding strategy: we aim to provide new tools of excellent quality to the molecular biology community. Therefore research and development is a continuous process within the company.
Production of recombinant enzymes guarantees competitive pricing for our customers and our thorough knowledge in the research field serves as a basis for prompt technical support. In recognition of our work in developing novel enzymes, Finnzymes has been awarded for being the most innovative company in Finland.
Fisher BioImage
Acquisition in 2006
Fisher BioImage ApS, a life science company, develops and sells assays for monitoring protein translocations and protein interactions in living cells. It provides Redistribution technology, which helps to monitor cell-based protein translocation assays using fluorescent protein reporters. The company offers assays to pharmaceutical and biotechnology companies, as well as to academic groups for basic research.
SwissAnalytic Group
Acquisition in 2007
SwissAnalytic Group develops and markets liquid chromatography pumps.
Ionalytics Corporation
Acquisition in 2005
Sensitivity, separation and detection are critical success factors in drug discovery. At Ionalytics, they have developed the Ionalytics SelectraTM, a front-end instrument that enhances the performance of mass spectrometers by providing dynamic ion filtering to:
- improve efficacy of data
- reduce drug development time
Based on FAIMS (high-Field Asymmetric waveform Ion Mobility Spectrometry) technology, the Ionalytics Selectra filters and focuses ions within a highly tuned electrical field contained within an electrode set. The result is increased productivity of mass spectrometers in both qualitative and quantitative applications.
The Ionalytics team is committed to providing innovative tools to help laboratory professionals determine a drug's potential for treating or curing illness. Comprised of seasoned business leaders, respected scientists and engineers with years of product development and support expertise, their collective talent and experience has resulted in a customer-oriented culture and a high performance instrument that helps bring new drugs to market quicker.
Linkage Biosciences, Inc.
Acquisition in 2017
Linkage Biosciences is a molecular diagnostics company developing products that hope to improve and expedite complex genetic testing. Their initial focus is on diagnostic products for solid organ and hematopoietic stem cell transplantation where their proprietary technology will have an impact. The company offers human leukocyte antigen testing products used in solid organ and hematopoietic stem cell transplantation, as well as provides pharmacogenomic and autoimmune disease testing and research and genetic marker tests.
Lingkage Biosciences was founded in 2004 and is based in
CRS Robotics
Acquisition in 2002
CRS develops laboratory integration hardware and software to control motion control devices (robots). The company designs, manufactures and markets integrated laboratory workstations, laboratory peripheral products and articulated robots for a variety of laboratory and advanced manufacturing processes.
Their core competence is the provision of standard automation solutions utilizing advanced proprietary software for the multi-billion dollar world biotechnology and pharmaceutical segments of the global Life Sciences market. CRS advanced software and motion control devices are used for drug discovery, gene sequencing, quality assurance and compound testing.
In addition, they supply robot automation products to niche advanced manufacturing and technology markets such as product and materials testing, machine and instrument loading, dispensing and deburring, applications, and for Research and Development and Educational Institutions.
CRS is a global company with sales, service and engineering centers throughout the global marketplace.
Prionics AG
Acquisition in 2014
One-Stop-Provider in farm animal diagnostics
As a world leader in the field of farm animal diagnostics we focus our efforts on meeting the needs of our customers by providing a unique bundle of expertise and diagnostic solutions. While expanding our business along the food value chain, Prionics has successfully grown from a pioneer and global leader in BSE testing to a one-stop-provider for farm animal diagnostics, including diagnostic tests for many zoonoses.
Our focus arises from our international clientele and their unique diagnostic issues that challenge us to continuously improve and expand our portfolio and make our solutions available around the world.
Biolab
Acquisition in 2009
Biolab Limited supplies laboratory products and analytical technologies to clients in Australia and New Zealand. It offers clinical diagnostic testing products, diagnostic imaging products, environmental monitoring and safety products, medical devices and consumables, process monitoring and industrial instruments, laboratory chemicals, laboratory equipment and furniture, life science research technologies, microbiology products, pathology equipment and supplies, and scientific instruments and automation solutions, as well as laboratory plasticware, glassware, and supplies.
picoSpin
Acquisition in 2012
picoSpin, LLC, Boulder, Colorado, USA, was founded in 2010 by its Chairman, Charles E. Miller, together with a team of scientists and engineers. The mission of picoSpin is to develop, manufacture, and market miniature NMR spectrometers. picoSpin’s products are used wherever chemists required rapid and cost-effective access to analytical spectroscopy. Proven applications include quality analysis, quality control, chemical education, and process development.
Advanced Scientifics (ASI)
Acquisition in 2015
ASI is a leading global provider of advanced single-use systems for the Healthcare and Life Sciences Industries. ASI’s manufacturing and corporate headquarters are in Pennsylvania, United States with an additional production facility in Matamoros, Mexico.
Cohesive Technologies
Acquisition in 2007
Cohesive Technologies Inc. designs, manufactures, and markets breakthrough liquid chromatography (LC) solutions for the drug discovery, pharmaceutical, contract research, and clinical diagnostic industries. The company has developed patented technologies and a wide range of chromatographic products designed to significantly improve productivity by accelerating the separation, purification, and analysis of molecules in bioanalysis.
With a strong depth of knowledge in column chemistry, applications, engineering, software development, and quality management, Cohesive Technologies leads the industry in the research, development, and production of LC technologies that accelerate the pace of customers' drug discovery and development efforts.
Spectronex
Acquisition in 2007
Spectronex is a leading supplier of mass spectrometry, chromatography and surface science instrumentation in Switzerland, Austria, Slovakia and the Czech Republic.
TKA Wasseraufbereitungssysteme
Acquisition in 2010
TKA Wasseraufbereitungssysteme GmbH provides laboratory water purification systems. It offers ion exchange cartridges, reverse osmosis systems, ultrapure water systems, high purity water systems, pretreatment systems, and water softeners, as well as other laboratory equipment and consumables. The company also provides accessories for ion exchange cartridges, mixed-bed resins, reverse osmosis systems, activated carbon filters, ultrapure water systems, measuring instruments, and digital and analog systems.
ABR--Affinity BioReagents
Acquisition in 2008
ABR--Affinity BioReagents, Inc. manufactures and distributes monoclonal and polyclonal antibodies, and recombinant proteins for the scientific research community. The company offers cell biology products that include apoptosis, cell adhesion and junctions, structure markers, and cytokines; cell signaling products, such as bioactive peptides, G protein-coupled receptors, kinases, membrane receptors, steroid receptors, and steroids hormones; controls, secondaries, and tags that include blocking peptides and secondary antibodies; and muscle biology, nuclear biology, neurobiology, and stem cell biology products. It also provides reagents and immunology services. ABR--Affinity BioReagents, Inc. markets its products through a network of distribution partners in Australia, Austria, Bahrain, Belgium, Brazil, Canada, Chile, China, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Hong Kong, Hungary, India, Ireland, Israel, Italy, Japan, Korea, Kuwait, Latin America, Latvia, Lithuania, Luxembourg, Malaysia, Mercosur, Mexico, the Netherlands, New Zealand, Norway, Poland, Portugal, the Russian Federation, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, Turkey, Ukraine, the United Arab Emirates, the United Kingdom, the United States, and Vietnam. The company was founded in 1989 and is based in Golden, Colorado. ABR--Affinity BioReagents, Inc. operates as a subsidiary of Pierce Biotechnology Inc.
Patheon
Acquisition in 2017
Patheon N.V. provides outsourced pharmaceutical development and manufacturing services in the Netherlands. The company operates through three segments: Drug Product Services, Pharmaceutical Development Services, and Drug Substance Services. It offers a range of active pharmaceutical ingredient and finished drug product services, including formulation development, as well as clinical and commercial-scale manufacturing, packaging, and lifecycle management. It caters its services to small molecule and large molecule biological drugs sectors. The company was formerly known as Patheon Holdings Coöperatief U.A. and changed its names to Patheon N.V. in June 2016. Patheon N.V. was incorporated in 2013 and is headquartered in Durham, North Carolina.As of September 13, 2017, Patheon N.V. operates as a subsidiary of Thermo Fisher (CN) Luxembourg S.à r.l.
Jouan SA
Acquisition in 2003
Jouan is a global supplier of products used by life science researchers in academic, pharmaceutical, biotech, and clinical markets to prepare and preserve laboratory samples.
Jouan's offerings include centrifuges, biological safety cabinets, ultra-low temperature freezers, and incubators. The company has also incorporated robotics into many of its products to meet the increased throughput requirements of researchers, and is a leading provider of automated centrifuges, freezers, and incubators. In addition to its own brand name, Jouan's products are sold worldwide under the Precision, NAPCO, Heto, Holten, and ALC brands. Jouan is based in Saint-Herblain, France, and has manufacturing operations in France, Denmark, Italy, the Czech Republic, and the U.S.
Phadia
Acquisition in 2011
At Phadia, they develop, manufacture and market complete blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases.
For more than 40 years, they have been focused on delivering results, and they are proud to report that, in that time, they have maintained leadership in allergy testing and become one of the world's leading autoimmune disease test providers.
Headquartered in Uppsala, Sweden, their international centre of excellence is at the heart of it all. The site of their strategic management, administration and business development activities, it’s also the home of extensive research and development as well as world-class manufacturing facilities. They also have a site in Southern Sweden, where development of their allergen raw materials takes place.
In Freiburg, Germany, a third centre of excellence develops, manufactures and supports diagnostic tests for autoimmune diseases. Recently, a fourth centre of excellence was established in Vienna, Austria, to handle the development and production of assay systems, based on multiplex technology, for both allergy and autoimmunity.
Together, these four centres enable us to remain focused on excellence as they respond to the diagnostic needs of the world.
Flux Instruments
Acquisition in 2007
In 1992 Flux Instruments was founded in the small industrial town of Karlskoga in Sweden.
The founders predicted an increasing potential for their novel HPLC pump, based on a radically new concept. Its secret? Hitherto unknown miniaturisation techniques leading to unsurpassed precision and micro flow capabilities.
With its R&D department near Munich in Germany and its manufacturing site in Sweden and Switzerland. Technology leadership and precision manufacturing have been given the highest priority. They will continue their innovative strategies and make sure to also fulfill your needs in the years to come.
High-Pressure-Liquid-Chromatography has outstanding world-wide growth, probably outperforming all other types of analytical instruments. In combination with MS has, the use of micro bore and capillary columns already are state-of-the-art, other areas in HPLC are likely to follow.
The necessity to deliver gradient HPLC flow in the low micro- and even nanoliter range has been their challenge from begin on. Today they offer the No. 1 system for microbore HPLC and have a clear leadership in this market segment.
Whether for applications in in life sciences, in proteomics research or in the area of high throughput analysis and fast analysis cycles, the miniaturized design of their instruments is the key to outstanding performance.
Ahura Scientific
Acquisition in 2010
Ahura Scientific Inc. develops rugged, ultra-compact, field-enabled optical systems for the immediate identification and authentication of liquid and solid chemical substances. Customers include agencies and companies in the homeland security, life sciences, industrial and medical markets. Manufactured in the USA in an ISO 9001-certified facility, the company's products offer exceptional portability and unparalleled performance.
IntegenX
Acquisition in 2018
IntegenX, Inc. designs, manufactures, and markets automation systems that enable reliable microsample preparation and analysis for the life sciences. It offers Apollo 100, a platform that allows the processing of DNA sequencing reactions; Apollo 200, an integrated sample preparation system for human DNA identification; microfluidics for DNA sequencing, molecular diagnostics, and human identification applications; and Apollo 324 system, a benchtop robotic workstation that automates the construction of DNA fragment libraries for next-generation sequencing. The company was formerly known as Microchip Biotechnologies, Inc. and changed its name to IntegenX, Inc. in March 2010. The company was incorporated in 2003 and is based in Pleasanton, California.
WuXi Diagnostics
Series B in 2021
WuXi Diagnostics builds an innovative model that enables diagnostic product innovation, generates clinical insights, and benefits the health of mankind through precision diagnosis and treatment.
